Navigation Links
Cepheid Reports Second Quarter Revenue of $42.1 Million
Date:7/24/2008

>Cash flows from operating activities:

Net loss $(9,376) $(11,394)

Adjustments to reconcile net loss to net

cash used in operating activities:

Depreciation and amortization 3,129 2,558

Amortization of intangible assets 2,310 2,050

Amortization of prepaid compensation expense 126 125

Stock-based compensation related to employees

and consulting services rendered 6,968 4,299

Deferred rent 376 8

Changes in operating assets and liabilities:

Accounts receivable 2,690 (6,884)

Inventory (4,419) (5,352)

Prepaid expenses and other current assets (1,239) (764)

Other non-current assets (161) 210

Accounts payable and other current

liabilities 5,333 545

Income taxes payable (213) -

Accrued compensation (210) 393

Accrued expense for patent-related matter - (3,350)

Deferred revenue (1,348) 1,921

Net cash provided by (used in)

operating activities 3,966 (15,635)

Cash flows from investing activities:

Capital expenditures (9,000) (2,955)

Payments for technology licenses - (4,737)

Cost of Sangtec acquisition, net of cash

acquired - (27,341)

Proceeds from maturities of marketable


'/>"/>
SOURCE Cepheid
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13

Related biology technology :

1. Cepheid Enters Into Five-Year Agreement With Northrop Grumman for the Purchase of Anthrax Test Cartridges for Use in United States Postal Service Biohazard Detection Systems
2. Cepheid to Present at Thomas Weisel Partners Healthcare Conference
3. Cepheid Enters Agreement To Exclusively License HPV Portfolio Developed by Quantovir AB
4. Cepheid to Present at William Blair Small-Cap Growth Stock Conference
5. Cepheid to Present at the Piper Jaffray 19th Annual Healthcare Conference
6. Cepheid Receives Health Canada Medical Device License for Xpert MRSA(TM) Test and GeneXpert(R) System
7. Cepheid Schedules Teleconference and Webcast for 2007 Fourth Quarter and Full Year Results
8. Cepheid Appoints Senior VP, Chief Financial Officer to Management Team
9. Cepheid and Instrumentation Laboratory Introduce Xpert(TM) HemosIL(R) FII & FV Assay to European Clinical Testing Market
10. Cepheid Reports Fourth Quarter and Full Year 2007 Results
11. Cepheid to Present at Cowen and Companys 28th Annual Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... This report is a professional ... For an overview analysis, the report introduces quartz ... structure, industry overview, policy analysis, and news analysis, ... has witnessed rapid development with key manufacturers increasing ... report mentions quartz tubing upstream raw materials and ...
(Date:12/17/2014)... December 17, 2014 Gene synthesis ... it has entered into a technology access and ... to apply DNA2.0’s proprietary protein engineering technology, known ... , “We are extremely excited that the global ... This proprietary bioengineering technology has now been ...
(Date:12/17/2014)...  Vermillion, Inc. (NASDAQ: VRML ), a ... the next step in its expanded strategy to rebuild ... the naming of current Chief Operating Officer, Valerie ... current Chairman of the Board and CEO James ... changes are effective January 1, 2015. "Jim ...
(Date:12/17/2014)... 2014 CASI Pharmaceuticals, Inc. (Nasdaq: ... development and commercialization of innovative therapeutics addressing cancer and ... a primary commercial focus on China ... Type C meeting with the U.S. Food and Drug ... in February 2015.  During this meeting the Company will ...
Breaking Biology Technology:2020 Quartz Tubing Market: Global Development & Forecasts Analysis Now at DeepResearchReports.com 2ADM and DNA2.0 Enter Into Protein Engineering Technology Access and Service Agreement 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 2CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 3CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 4CASI Pharmaceuticals Granted Type C Meeting With U.S. FDA For ENMD-2076 In Fibrolamellar Carcinoma 5
... - Gov Jim Doyle on Thursday announced that three ... from the Department of Commerce Technology Assistance Grant (TAG) ... are as follows: , , Functional Biosciences, ... to provide DNA sequencing. It will receive a $250,000 ...
... Thompson announced last week that he is planning to ... arm that will provide access to his electronic medical ... Alumni Research Foundation announced that it has licensed California ... cell patents. On another note, Madison biotech firm ...
... Alfalight, Inc. , a Madison-based manufacturer of high-power ... been awarded $1.4 million in funding for Phase II ... by the Defense Advanced Research Projects Agency. ... increase a laser's power conversion efficiency -- to lower ...
Cached Biology Technology:Alfalight garners $1.4 million defense funding for diode program 2
(Date:12/10/2014)... NEW YORK , Dec. 8, 2014 You,ve ... online banking account but can,t remember your password, site key ... birthday? Who was your first grade teacher? ... launches the app that will finally put an ... PINs – 1U TM . 1U leverages a ...
(Date:12/10/2014)... 9, 2014  Wake Forest Baptist Medical Center today announced ... School of Medicine. Funding for this $50 million capital ... will be publicly launched next summer. ... former 60 series R.J. Reynolds Tobacco Company complex, adjacent ... begin immediately with plans to be ready to welcome ...
(Date:12/10/2014)... Research and Markets ( http://www.researchandmarkets.com/research/xclcvw/biometrics_market ... "Biometrics Market in Japan 2014-2018" report to ... The integration of biometrics and ... and upgradation of the driver,s license is one ... Besides the aforementioned projects, biometrics is being used ...
Breaking Biology News(10 mins):The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 2The Password is Finally Dead: Launch of 1U Mobile App Eliminates Need for All Usernames and Passwords 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Biometrics Market in Japan 2014-2018: Key Vendors are DDS, Fujitsu, Hitachi and NEC 2
... February 20, 2013As the nations of the world prepare ... endangered sharks in early March, a team of researchers ... oceanic whitetip shark regularly crosses international boundaries. Efforts ... within their own maritime borders may therefore need to ...
... programs that include dietary advice coupled with behavioral counseling ... approach for men and women with significant weight loss ... conducted by researchers at the Jean Mayer USDA Human ... Employees enrolled in the intervention arm of a randomized ...
... among the elements that make up today,s smorgasbord of planets, ... and his colleagues hope to learn how our solar system ... the University of California, San Diego, has worked on this ... his team has found the Chemical Dynamics Beamline of the ...
Cached Biology News:New research on migratory behavior of oceanic whitetip sharks can help shape conservation strategies 2New research on migratory behavior of oceanic whitetip sharks can help shape conservation strategies 3Employees shed pounds in worksite-based weight loss intervention with behavioral counseling 2Employees shed pounds in worksite-based weight loss intervention with behavioral counseling 3Searching for the solar system's chemical recipe 2Searching for the solar system's chemical recipe 3Searching for the solar system's chemical recipe 4Searching for the solar system's chemical recipe 5
The 12-Tube Magnetic Separation Rack is designed to be used for small-scale separations using magnetic particles. ,Capacity: 12 microcentrifuge tubes. ,Magnets: Neodymium rare earth permanent ma...
...
No description available in Ensembl Antigen: Recombinant Protein Epitope Signature Tag (PrEST)....
15(S)-HETE-d8 is used as an internal standard for the quantification of 15(S)-HETE by stable isotope dilution mass spectrometry....
Biology Products: